Health Care & Life Sciences » Biotechnology | Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc. | Ownership

Companies that own Lexicon Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Invus Public Equities Advisors LLC
60,240,864
56.9%
1,966,214
23.37%
06/30/2018
Fidelity Management & Research Co.
15,874,780
14.99%
36,006
0.02%
06/30/2018
Ulys LLC
4,321,214
4.08%
0
100%
06/30/2018
BlackRock Fund Advisors
4,078,125
3.85%
76,317
0%
06/30/2018
The Vanguard Group, Inc.
3,673,742
3.47%
14,090
0%
06/30/2018
UBS AG (Investment Management)
2,393,061
2.25%
36,968
0.02%
06/30/2018
SSgA Funds Management, Inc.
2,000,545
1.89%
-670,584
0%
06/30/2018
ClearBridge LLC
1,299,917
1.23%
127,800
0.31%
06/30/2018
UBS Asset Management (Americas) Inc.
1,077,749
1.02%
-48,436
0.03%
06/30/2018
Sector Asset Management AS
862,602
0.82%
8,010
1.52%
06/30/2018

About Lexicon Pharmaceuticals

View Profile
Address
8800 Technology Forest Place
The Woodlands Texas 77381
United States
Employees -
Website http://www.lexpharma.com
Updated 07/08/2019
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It also offers programs in clinical development for diabetes, irritable bowel syndrome, and carcinoid syndrome. The company was founded by Brian P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.